SKF 14336 versus schizophrenia.
作者信息
DeVito R A, Sykes D E, McDonald E K, Larson J L, Smith J A
出版信息
Dis Nerv Syst. 1969 Jun;30(6):405-6.
PMID:5809295
Abstract
摘要
相似文献
1
SKF 14336 versus schizophrenia.司可巴比妥14336与精神分裂症
Dis Nerv Syst. 1969 Jun;30(6):405-6.
2
Double blind study of an acridan derivative (SK & F 14336) versus chlorpromazine.一种吖啶衍生物（SK&F 14336）与氯丙嗪的双盲研究。
Curr Ther Res Clin Exp. 1968 May;10(5):223-30.
3
Clomacran and chlorpromazine in psychotic outpatients: a controlled study.氯麦克兰与氯丙嗪治疗门诊精神病患者：一项对照研究。
Curr Ther Res Clin Exp. 1971 Jun;13(6):337-43.
4
Controlled comparison of SK&F 14336 and chlorpromazine in newly admitted schizophrenics.
J Clin Pharmacol J New Drugs. 1969 Sep-Oct;9(5):328-38.
5
A transcultural study with clomacran: comparison of two assessment methods.
Curr Ther Res Clin Exp. 1974 Sep;16(9):971-89.
6
A clinical evaluation of a new psycholeptic acridan compound, SKF-14336.一种新型精神抑制吖啶化合物SKF - 14336的临床评估。
Curr Ther Res Clin Exp. 1967 Sep;9(9):477-81.
7
A double blind study of clomacran.氯麦克兰的双盲研究。
Curr Ther Res Clin Exp. 1969 May;11(5):300-6.
8
Proceedings: Clomacran in the treatment of schizophrenic patients--a comparison of two assessment methods.会议论文：氯麦克兰治疗精神分裂症患者——两种评估方法的比较
Psychopharmacol Bull. 1976 Jan;12(1):30-1.
9
A clinical study of a new nonphenothiazine tranquilizer (SK&F--14336).一种新型非吩噻嗪类镇静剂（SK&F - 14336）的临床研究。
Curr Ther Res Clin Exp. 1969 Apr;11(4):178-81.
10
Clomacran in the treatment of schizophrenic patients: a comparison of two assessment methods.氯麦克兰治疗精神分裂症患者：两种评估方法的比较。
Int J Clin Pharmacol Biopharm. 1975 Jun;11(4):299-303.
Zotero 插件